2003
Morbidity and mortality in obstructive sleep apnea syndrome 2: Effect of treatment on neuropsychiatric morbidity and quality of life
AL‐BARRAK M, Shepertycky M, Kryger M. Morbidity and mortality in obstructive sleep apnea syndrome 2: Effect of treatment on neuropsychiatric morbidity and quality of life. Sleep And Biological Rhythms 2003, 1: 65-74. DOI: 10.1046/j.1446-9235.2003.00008.x.Peer-Reviewed Original ResearchContinuous positive airway pressureQuality of lifeNeuropsychiatric problemsObstructive sleep apnea syndrome (OSA) resultsAutomobile accident ratesNocturnal oxygen desaturationPositive airway pressureFragmentation of sleepEffect of treatmentOxygen desaturationAirway pressureOSA patientsResidual abnormalitiesCommon presentationNeuropsychiatric sequelaeNeuropsychiatric morbidityNeuropsychiatric abnormalitiesElectroencephalographic arousalSyndrome 2Syndrome resultsPatientsLife issuesMorbidityOSASAbnormalities
2002
Quality of Life After Prophylactic Oophorectomy
Daly M. Quality of Life After Prophylactic Oophorectomy. 2002 DOI: 10.21236/ada412199.Peer-Reviewed Original ResearchProphylactic oophorectomyPhysical consequences of surgeryArray of coping strategiesQuality of life issuesQuality of lifeRisk assessment programMultidimensional qualityHealth decisionsPhysical sequelaeAwareness effortsConsequences of surgeryLife issuesSocial functioningPilot studyLong-term effectsWomenPost-surgical changesAssessment ProgramOophorectomyAlternative therapy strategiesSurgery optionsOvarian cancerPhysical consequencesTherapy strategiesHealth
2001
Quality of Life Issues Among Women Undergoing High-Dose Chemotherapy for Breast Cancer
Partridge A, Bunnell C, Winer E. Quality of Life Issues Among Women Undergoing High-Dose Chemotherapy for Breast Cancer. Breast Disease 2001, 14: 41-50. PMID: 15687635, DOI: 10.3233/bd-2001-14106.Peer-Reviewed Original ResearchHigh-dose chemotherapyOverall QOLPhysical functioningBreast cancerAutologous stem cell supportHigh-dose therapyStem cell supportDose chemotherapyTransplant resultsPatients' qualityConsiderable symptomsQoL findingsRole functioningTransient impairmentChemotherapyCell supportQoLSexual functioningLife issuesPatientsCognitive functioningTherapySymptomsCancerAdditional research
1996
Quality‐of‐Life in Patients Receiving Implantable Cardioverter Defibrillators At or Before Age 40
DUBIN A, BATSFORD W, LEWIS R, ROSENFELD L. Quality‐of‐Life in Patients Receiving Implantable Cardioverter Defibrillators At or Before Age 40. Pacing And Clinical Electrophysiology 1996, 19: 1555-1559. PMID: 8946450, DOI: 10.1111/j.1540-8159.1996.tb03180.x.Peer-Reviewed Original ResearchConceptsICD placementYounger patientsSF-36 health questionnaireMore young patientsModerate physical activityTime of ICDImplantable cardioverter defibrillatorElectrophysiology serviceICD implantationOlder patientsICD dischargesSuch patientsHealthy infantsHealth QuestionnaireCardioverter defibrillatorPhysical activityAge 40Daily livingPatientsICD increasesHigher education levelMean timeICDLife issuesBody image concerns
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply